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JIn 1999, IOM issued a report that recommended that the Centers for Disease Control and
Prevention should disseminate evidence-based HIV prevention interventions (EBIs) to be
implemented by health departments, community-based organizations, drug treatment centers,
and clinics. Based on these recommendations, the Diffusion of Effective Behavioral Interventions
Project was initiated in 2000 and began disseminating interventions into public health practice. For
15 years, the Centers for Disease Control and Prevention has disseminated 29 EBIs to more than
11,300 agencies. Lessons were identiﬁed during the 15 years of implementation regarding successful
methods of dissemination of EBIs. Lessons around selecting interventions for dissemination,
developing a dissemination infrastructure including a resource website (https://effectiveinterven
tions.cdc.gov), and engagement with stakeholders are discussed. A continuous development
approach ensured that intervention implementation materials, instructions, and technical assistance
were all tailored to the needs of end users, focus populations, and agency capacities. Six follow-up
studies demonstrated that adopters of EBIs were able to obtain comparable outcomes to those of the
original efﬁcacy research. The Diffusion of Effective Behavioral Interventions Project may offer
guidance for other large, national, evidence-based public health dissemination projects.
(Am J Prev Med 2016;51(4S2):S140–S147) Published by Elsevier Inc. on behalf of American Journal of
Preventive Medicine. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).IntroductionIn 1999, IOM issued a report, “No Time to Lose,”which recommended that the Centers for DiseaseControl and Prevention (CDC) disseminate
evidence-based HIV prevention interventions (EBIs).1
Based on these recommendations, the Diffusion of Effec-
tive Behavioral Interventions (DEBI) Project was initia-
ted in 2000 by CDC’s Division of HIV/AIDS Prevention.
The goal was to develop a national-level dissemination
project and provide training, technical assistance, and
capacity building on EBIs to health departments and
community-based organizations (CBOs). This paper
identiﬁes lessons learned from the DEBI Project.$36.00
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Prev Med 2016;51(4S2):S140–S147 Published by Else
an open access article under the CC BYThe DEBI Project built upon CDC’s Prevention
Research Synthesis (PRS) Project2 and the Replicating
Effective Programs (REP) Project.3 DEBI, PRS, and REP
are components of the Division of HIV/AIDS Preven-
tion’s Research to Practice Model,4 which represents the
steps the Division undertakes when moving HIV pre-
vention research into practice. In this model, PRS ﬁrst
identiﬁes EBIs that meet CDC’s criteria for efﬁcacy (i.e.,
candidates for dissemination).5 REP then develops inter-
vention packages in partnership with the original efﬁcacy
researcher6 and, ﬁnally, DEBI disseminates interventions
into prevention practice.7 After 15 years, PRS has iden-
tiﬁed 93 interventions as meeting CDC’s criteria for
efﬁcacy, 25 of which have been packaged by REP. DEBI
has packaged an additional 11 interventions.8 Of the 36
developed packages, 29 have been disseminated to more
than 11,300 implementing agencies, including CBOs,
health departments, drug treatment facilities, and medi-
cal clinics. In 2015, CDC reduced the number of dis-
seminated EBIs in an effort to prioritize interventions
with lower delivery costs that reach highest risk popu-
lations. CDC will continue to fund agencies that imple-
ment the Community PROMISE (Peers Reaching Out
and Modeling Intervention Strategies); Mpowerment;vier Inc. on behalf of American Journal of Preventive Medicine. This is
-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Choosing Life: Empowerment! Action! Results!); Part-
nership for Health; Healthy Relationships; WILLOW
(Women Involved in Life Learning from Other Women);
CONNECT; START; Sister to Sister; Many Men, Many
Voices; Personalized Cognitive Counseling; VOICES/
VOCES (Video Opportunities for Innovative Condom
Education and Safer Sex); and Safe in the City inter-
ventions.9–23 A conservative estimate would be that $100
million ($500,000 on packaging, $2,000,000 on website
resources, $22,000,000 on training and technical assis-
tance, $75,500,000 in implementation) was devoted per
year to dissemination and implementation of EBIs.
Dissemination was a ﬂuid process involving partner-
ships with the original efﬁcacy researchers, dissemination
agents, and end users of the interventions. Nineteen
behavioral scientists worked in intervention-speciﬁc
teams, referred to as the DEBI teams in this paper, and
were assigned the task of working with the original
researchers, training experts, and capacity builders to
disseminate a particular EBI. In 2002, there were two
interventions in active dissemination but by 2004 there
were 11.
The DEBI teams integrated a continuous development
strategy into the Project based on concepts from Devel-
opmental Evaluation.24 The DEBI teams integrated
evaluation activities designed to identify dissemination
challenges in real time in order to facilitate deployment.
As part of this strategy, DEBI teams integrated formative
evaluation activities into routine program management
and were asked to document decisions, action steps,Table 1. Lessons Learned From Dissemination of Evidence-Bas
1 There are multiple factors to consider when selecting EBIs for d
conditions, so a systematic way to select interventions is need
2 Determine whether to issue packaged intervention materials o
3 Core elements must be clearly articulated and their implemen
disseminators, researchers, and implementers.
4 Agencies engaged in dissemination of EBIs must explore copy
5 Agencies that disseminate EBIs should develop a funding struc
6 Agencies should consider the use of electronic technology to in
7 Roles of the original researchers should be fully deﬁned in the
8 An EBI dissemination project will be more effective if marketin
9 Risk context should inform dissemination design. Disseminatio
inﬂuence the adoption of risk reduction and health promoting b
reﬂect the context of risk in various focus populations and thu
10 Agencies should determine whether capacity building should fo
target the capacities needed for EBI implementation.
11 Disseminating agencies must plan for adoption resistance and
EBI, evidence-based HIV prevention intervention.
October 2016techniques, and technologies used with regards to
intervention dissemination. Evidence supporting the
lessons learned described in this paper was gathered
from multiple sources, including training assessments
and quality assurance activities, implementation mon-
itoring instruments, user acceptability tools, a database
of approximately 500–700 annual technical assistance
requests, CDC site visit and grantee quarterly reports,
and website utilization. These formative and process data
allowed the DEBI teams to provide monitoring and
quality control over dissemination and ensure that EBIs
were brought to scale. The aforementioned data, along
with reﬂections from expert opinion and experience, and
feedback from end users served as the foundation for the
continuous development strategy.
During the past 15 years, lessons have been gleaned
from the DEBI Project (Table 1). These lessons can
provide insights to federal agencies or other organiza-
tions as they begin to translate public health research
ﬁndings to community-based programming.25
Lesson One
There are multiple factors to consider when selecting
EBIs for dissemination. Not all EBIs are feasible for
delivery under real-world conditions, so a systematic way
to select interventions is needed for an efﬁcient dissem-
ination system. The agency responsible for dissemination
must select interventions with the greatest impact
potential while also ensuring that technology contained
within the intervention is contextually appropriate. EBIed Interventions for HIV Prevention
issemination. Not all EBIs are feasible for delivery under real-world
ed for an efﬁcient dissemination system.
r practice guidelines.
tation must involve translation and technology exchange among
right and intellectual property issues.
ture that ensures resources for implementation and sustainability.
crease access to intervention resources, materials, and training.
dissemination process.
g is integrated into the strategy.
n of health-related interventions requires a set of strategies that
ehaviors. A dissemination strategy should allow for adjustments to
s better ﬁt the intervention to its setting.
cus on building the general capacity of implementing agencies or
develop issue management strategies.
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in the focus population, implementation costs, sustain-
ability of effects, intervention complexity, and feasibility
of real-world implementation. In the experience of the
DEBI teams, there are several criteria that make inter-
ventions more desirable for implementation. Interven-
tions that have repeatedly demonstrated results in several
studies are more likely to be successfully replicated in
real-world settings. Likelihood of success may increase if
the intervention has demonstrated positive ﬁndings
among more than one subpopulation using multiple
delivery mechanisms. For example, Mpowerment, an
intervention designed to reach white, Latino, and African
American young gay men with risk reduction messages,
has been successfully implemented at social opportunity
events, via venue-based outreach through small group
sessions, and through social networks.10
Initially, the DEBI teams were faced with the situation
of having too few intervention options for men who have
sex with men (MSM), the population most disproportion-
ately affected by HIV.5,6 CDC’s Compendium of Effective
Interventions identiﬁed twice as many EBIs for hetero-
sexuals as compared with MSM.6 Even fewer EBIs were
designed to be culturally appropriate for African Ameri-
can MSM, the subgroup with the highest HIV burden.
In an effort to address this issue, CDC took a two-
pronged approach: evaluation of an adapted EBI and
evaluation of a promising locally developed intervention.
In the case of d-up: Defend Yourself!, CDC funded a
cultural adaptation of an EBI primarily tested with
Caucasian MSM12 and evaluated the outcome.11 The
adapted intervention, d-up: Defend Yourself!, was effective
in promoting condom use among African American
MSM. Many Men, Many Voices was a small group HIV/
sexually transmitted infection prevention intervention
developed by an African American MSM-serving CBO.
CDC funded an outcome evaluation of this intervention
demonstrating that Many Men, Many Voices signiﬁcantly
reduced the sexual risk behaviors of African American
MSM, and laid the groundwork for dissemination.20
Lesson Two
Planning must determine whether to issue packaged
intervention materials or practice guidelines. A consid-
eration when implementing a dissemination project is
determining the mechanism by which information will
be diffused. CDC considered two mechanisms for DEBI:1. intervention implementation packages that replicated
the procedures of the efﬁcacy trial step by step; and2. prevention practice guidelines that would provide
broad, general guidance.The primary end users of EBIs were anticipated to be
CBOs. As such, the DEBI teams determined that detailed
step-by-step intervention materials were most appropri-
ate for implementing organizations whose staff often
lacked academic degrees. Community activists and
academicians offered perspectives from the ﬁeld that
explored the implementation challenges of packaged
interventions.26–28
Consideration also had to be given to whether the
packages should be static or mutable. The DEBI teams
decided to treat packaged materials as mutable, viewing
them as “living documents” that could and would be
updated and adapted based upon emerging research,
local knowledge, and practice-based updates.29 DEBI
teams assumed that the evidence base is ever evolving.29
The decision to take this continuous improvement
approach was inﬂuenced by the need for adaptations
to allow interventions to ﬁt agency context (e.g., operat-
ing hours, conﬁdentiality procedures, staff capacities and
training levels, funding) while maintaining ﬁdelity to the
core elements. Adaptation to community context was
more applicable to community-level interventions than
to scripted individual- and group-level interventions.
The DEBI teams collaborated with original researchers
to ensure that all practice-based updates were appro-
priate. Updating materials increased opportunities for
identiﬁcation of practice-based innovations because
modes of delivery change and need to be updated.29
For example, PROMISE, a community-level interven-
tion originally designed to use printed role model stories
to increase condom use, was updated to include social
media role model stories around HIV medication
adherence.9
Lesson Three
Core elements must be clearly articulated and their
implementation must involve translation and technology
exchange among disseminators, researchers, and imple-
menters. DEBI core elements are the characteristics of an
individual intervention presumed to be responsible for
the efﬁcacy of the intervention.30 Intervention efﬁcacy is
dependent on the ﬁdelity of core element implementa-
tion. Fidelity can be challenging in real-world settings
when opportunities for adaptation present themselves,
particularly if the core elements are not clearly deﬁned, if
their dosage is not speciﬁed, or if they are not clearly
sequenced.
Not all EBIs originally included deﬁned “core ele-
ments.” Few EBI studies had conducted mediation
analyses and fully factorial trails, which would have
provided valuable information on the relative impact of
each intervention component.29 The REP and DEBIwww.ajpmonline.org
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during the packaging process to identify core elements.
One resource for the development of core elements was
the original efﬁcacy research publication. Interventions
were more complex than described in the original
publication where page limits and the focus on efﬁcacy
limited the level of detail.
Core elements from original efﬁcacy studies needed to be
translated to facilitate efﬁcacy when disseminated nationally.
This process took the form of technology exchange among
original researchers, trainers, technical assistance providers,
and implementation staff. For example, clinic staff indicated
that the Sister to Sister, a brief, one-on-one, risk reduction
behavioral intervention delivered to sexually active African
American women via a nurse during the course of a routine
medical visit, could also be delivered by patient educators.19
Dr. Loretta Jemmott, the intervention developer, agreed.
This resulted in a change to the original core element that
required the intervention to be delivered by a nurse. Also,
Dr. Rotheram-Borus was able to translate the core elements
for the CLEAR intervention, a scripted individual-level
intervention, to ﬁt case management protocols.13 A dissem-
ination approach built upon technology exchange implies
that staff from implementing agencies have much to teach
the DEBI team around that particular intervention as it is
implemented in a range of sites.
Lesson Four
Agencies engaged in dissemination of EBIs must explore
copyright and intellectual property issues. EBIs must be
translated from the activities described in the original
efﬁcacy paper into packaged implementation materials
that may be copyrighted or considered the intellectual
property of the agency or university where the original
efﬁcacy research was conducted. As part of the selection
of an EBI, time and costs of copyright and intellectual
property must be addressed.
Lesson Five
Agencies that disseminate EBIs should develop a funding
structure that ensures resources for implementation and
sustainability. CDC has historically supported evidence-
based HIV prevention programs via grants and cooper-
ative agreements competed through funding announce-
ments. With the roll out of the Affordable Care Act and
associated health reform, it is possible that current
funding structures for evidence-based HIV prevention
services may shift to a reimbursement model.
Beginning in 2004, CDC released multiple funding
announcements to support the implementation of EBIs
(e.g., PS 04-064, PS 10-1003, PS 11-1113, PS 15-1502).October 2016Demand for EBIs increased dramatically with each
federal funding announcement that endorsed EBIs.
Through a process of policy dissemination, health
departments followed suit by funding evidence-based
HIV prevention within their state, city, or county.31
Lesson Six
Agencies should consider the use of electronic technol-
ogy to increase access to intervention resources, materi-
als, and training. Technology can facilitate the adoption
of EBIs. Making intervention materials available through
a user-friendly website can ensure that materials are
available to implementing agencies. The DEBI Project
supported the maintenance of an intervention resource
website, https://effectiveinterventions.cdc.gov. The DEBI
teams observed that making intervention materials
available on the website prior to and after face-to-face
training minimized implementation barriers. The DEBI
teams developed a range of products that were added to
the website for use by implementing agencies, including
project budgets, job descriptions for implementation
staff, fact sheets for community distribution, guides for
program managers and frontline staff delivering the
interventions, and demonstration videos. A recent inven-
tory identiﬁed 940 implementation support products
housed on the intervention resource website (https://
effectiveinterventions.cdc.gov) that are free to the public.
The training component of the DEBI dissemination
system considered costs and beneﬁts of face-to-face train-
ing compared with online training. From January 1, 2002,
to September 30, 2015, a total of 28,782 people were
trained how to implement various EBIs at 1,862 face-to-
face trainings. However, face-to-face training delivery has
considerable costs. The use of online trainings offered the
beneﬁts of lower training costs, consistency, quality
control, as well as providing opportunity for refresher
trainings and real-time updates. The decision to translate a
particular face-to-face intervention training to an online
training was based upon the amount of skills building and
role play required to master implementation skills. Activ-
ities such as interviewing or group facilitation techniques
are more challenging in online formats. A total of eleven
EBIs were developed as online trainings, including four
HIV medication adherence interventions to support
CDC’s most recent emphasis on biomedical strategies to
prevent HIV transmission.32
Lesson Seven
Roles of the original researchers should be fully deﬁned in
the dissemination process. The DEBI teams found that the
original efﬁcacy researcher(s) and their organization(s)
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semination efforts, but could play a role in aspects of the
dissemination process, such as materials development,
piloting, training, and technical assistance.
When CDC determined that an EBI should be
disseminated, the DEBI teams and original researchers
worked to deﬁne the role of the researchers in the
dissemination process. Researchers could take on a range
of roles in dissemination, including provision of imple-
mentation support and development of curricula and
evaluation tools. Some researchers were interested in
providing direct intervention-speciﬁc technical assis-
tance, whereas others were interested in training indi-
viduals to implement the EBI. The DEBI teams consulted
researchers on issues of ﬁdelity and adaptation and
assumed training or technical assistance roles that the
original researchers did not wish to undertake such as
training quality assurance and observational site visits.
Lesson Eight
An EBI dissemination project will be more effective if
marketing is integrated into the strategy. Webcasts for
CDC grantees were used in the dissemination project and
were accompanied by distribution of marketing videos
that included interviews with researchers and endorse-
ments by members of the focus populations for whom
the intervention was intended. Over time, the DEBI
teams began to rely less on webcasts of information to
end users and more on social networks of HIV preven-
tion providers as a marketing strategy.
As the DEBI Project rolled out, CDC recognized the
need to integrate concepts from marketing33 and diffu-
sion of innovations34 into the DEBI Project. This
integration resulted in a marketing strategy that focused
on compatibility, observability, identiﬁcation of adopter
categories, use of social networks, and appeals to key
stakeholders. Compatibility with other prevention and
care services was emphasized. Observability was
enhanced by dissemination of videos that demonstrated
implementation under real-world conditions. Adopter
categories, such as CBOs, medical clinics, substance
abuse treatment programs, and health departments, were
analyzed to determine what messages would be most
effective with each adopter category to enhance evidence-
based practice. Social networks and opinion leaders
within these networks helped identify individuals to
endorse EBIs. Key stakeholders made decisions about
what interventions would be implemented at a particular
agency; thus, their perceptions of EBIs should be
addressed.
Focus populations are most receptive to interventions
designed and tested for them. Therefore, disseminationstrategies utilized photographic images of members of
the various intervention populations in materials and
videos. DEBI teams discovered that the videos that most
resonated with focus populations included actors who
were members of their cultural, racial/ethnic, and gender
groups. Videos required updates and adaptations to
remain appealing to and relevant for focus populations.
Lesson Nine
Risk context should inform dissemination design. Dis-
semination of health-related interventions requires a set
of strategies that inﬂuence the adoption of risk reduction
and health promoting behaviors. A dissemination strat-
egy should allow for adjustments to reﬂect the context of
risk in various focus populations and thus better ﬁt the
intervention to its setting.29 The DEBI Project included
components designed to be responsive to these needs,
including:1. engagement with key stakeholders and opinion leaders
to determine what images and messages will be relevant
and should be imparted to high-risk focus populations,
for example; engaging male-to-female transgender
individuals, who may or may not respond to messages
designed for MSM or heterosexual women;2. understanding risk and protective behaviors in real-
world settings such as run-away youth engaged in
survival sex for food and shelter;3. exploration of individual (e.g., reading level and
language preference), social, cultural, and economic
conditions that impact the focus population’s deci-
sions about their health;4. design and pretesting of familial and appropriate sexual
relationship messaging, such as messaging addressing
relationship dynamics for HIV-discordant couples17;5. engagement of community spokespeople and opinion
leaders to assist in dissemination of messaging around
the intervention; and6. identiﬁcation of incentives that help move focus
populations toward health-promoting behaviors.
Formative evaluation techniques such as qualitative
assessment of key informant interviews facilitated this
process.
Lesson Ten
Agencies should determine whether capacity building
should focus on building the general capacity of imple-
menting agencies or target the capacities needed for EBI
implementation. The distinction between general agency
capacity and intervention-speciﬁc capacity is a keywww.ajpmonline.org
Collins and Sapiano / Am J Prev Med 2016;51(4S2):S140–S147 S145concept in some dissemination models, such as the
interactive systems framework.35,36 It is often assumed
that intervention speciﬁc capacities must be built for an
agency to correctly implement an EBI. Between Novem-
ber 18, 2009, and June 3, 2013, CDC provided 418
episodes of capacity building to 129 CBOs implementing
EBIs. Of these episodes, 132 (31.6%) were for general
capacities and 207 (49.5%) were for intervention-speciﬁc
capacities. Between April 1, 2014, and February 8, 2016,
CDC provided 1,473 episodes of capacity building to 772
CBOs implementing EBIs. Of these episodes, 367 (47.4%)
were for general capacities, 197 (25.5%) were for EBIs for
HIV-positive individuals, and 101 (13.1%) were for EBIs
for HIV-negative individuals. Data gathered through the
DEBI Project revealed that agencies that need extensive
general capacity building will not beneﬁt from
intervention-speciﬁc capacity building activities until
underlying weaknesses in infrastructure, management,
and personnel are addressed.
Technical assistance is a method by which agency
capacity may be enhanced. The DEBI teams found that
by the time implementing agencies asked for help,
agencies had often encountered challenges that would
have been avoided if they had received technical assistance
early during the implementation process. For example,
recruitment and retention of the focus population into
interventions without use of incentives often requires
technical assistance around creative and relevant methods
to engage the focus population. Asking for technical
assistance may be viewed by many implementing agencies
as an indicator that they are not capable of implementing
the intervention, so technical assistance is not requested
until the agency has reached a crisis point. For this reason,
initiating a scheduled proactive approach to technical
assistance removes the stigma and identiﬁes implementing
agencies that are having difﬁculty with implementation
early in the process so that corrective action can be taken.
Technical assistance should be normalized and included as
a formal step in the implementation process.
Lesson Eleven
Disseminating agencies must plan for adoption resistance
and develop issue management strategies. End user choice
of EBIs reduces resistance to EBI practice and allows for
better ﬁt of the intervention technology. Customer-focused
dissemination efforts involved listening to end users to
determine what types of interventions they wished to
implement. Whether an intervention was found to be
efﬁcacious with a particular focus population is a prime
consideration when agencies adopt an intervention. Dis-
semination of EBIs into an existing ﬁeld of practice may be
met with end user resistance. During 1989–2002, CDCOctober 2016funded community-based HIV prevention providers to
implement locally developed interventions before moving
toward dissemination of EBIs in 2002.7 Condom distribu-
tion was the most common form of locally developed
intervention at the time. Group- or individual-level inter-
ventions that required recruitment and retention of the
focus population generally were not being implemented.
Community-based HIV prevention providers initially
viewed CDC’s shift to supporting EBIs with skepticism.
Although adoption of EBIs by CBOs increased over the
past 15 years, DEBI has never been fully embraced by
community HIV prevention providers. This may be
attributed to several factors: EBIs are often more proce-
durally complex than locally developed interventions;
training CBO employees on locally developed interven-
tions can be done on the job as opposed to EBIs; and
locally developed interventions may require a shorter time
commitment from the participant, which can facilitate
retention. Key stakeholders in both the advocacy and
academic communities have highlighted systematic faults
with DEBI.26 The DEBI teams have tried to respond by
adjusting strategic components of the dissemination
project to be more inclusive of community input.37
The DEBI teams found that it was important to distin-
guish between adoption resistance and partial implementa-
tion of an intervention. This was important because some
implementing agencies took longer to conduct formative
evaluation to “ﬁt” the intervention into local context and
agency capacity; this was particularly true for community-
level interventions, which generally took longer for CBOs to
roll out than did group- or individual-level interventions.
This was often attributed to the lack of experience of
adopting agency staff with formative evaluation strategies
such as key informant interviews and focus groups. In some
instances, the DEBI teams observed that interventions were
only partially implemented in the ﬁrst year of funding and
some agencies continued to implement locally developed
intervention activities and EBIs simultaneously.
The work of Rogers34 guided the DEBI team’s approach
to managing this resistance. Implementing half of an EBI
was viewed as half compliant rather than half non-
compliant, an issue-framing approach that focuses on
persuasion and skills building. CDC also worked to
identify the best locally developed interventions and
provided them adequate evaluation funding to determine
if the locally developed intervention signiﬁcantly changed
behaviors,20 demonstrating that CDC was invested in
practice-based evidence as well as evidence-based practice.
Discussion/Conclusions
Integrating a continuous development strategy was
critical to the success of the DEBI Project. This process
Collins and Sapiano / Am J Prev Med 2016;51(4S2):S140–S147S146led to the identiﬁcation of intervention-speciﬁc improve-
ments that were tailored to end users, focus populations,
and agency capacities. Information obtained during the
dissemination of individual interventions was used to
improve training, technical assistance, capacity building,
and intervention-speciﬁc implementation materials
located on the DEBI website, https://effectiveinterven
tions.cdc.gov/. It also improved the dissemination proc-
ess for other EBIs and resulted in improvements to the
dissemination project as a whole.
Since 2001, CDC has shifted the community HIV
prevention program paradigm from locally developed
interventions to EBIs developed for speciﬁc popula-
tions.38 This includes capacitating thousands of CBOs
staffed primarily by community members to implement
theory-based interventions with a high degree of ﬁdelity.
The real test of such a large dissemination system would
be whether end-users are able to obtain behavioral
outcomes comparable to the original efﬁcacy research.
A series of outcome evaluation studies were funded by
CDC to determine if CBOs implementing EBIs in the
ﬁeld obtain outcomes similar to those achieved in the
original efﬁcacy research. Findings from these studies
indicate that CBOs implementing these interventions in
real-world settings were able to obtain and maintain
outcomes similar to those observed by the original
researchers.38–42 The DEBI Project, which shifted the
ﬁeld of HIV prevention toward evidence-based practice,
was an essential component of the broader HIV pre-
vention landscape.38 CDC has initiated High Impact
Prevention, which supports the dissemination and imple-
mentation of cost-effective EBIs for focus populations
with the highest HIV incidence. High Impact Prevention
is primarily a biomedical model with increased emphasis
on antiretroviral treatment, pre- and post-exposure
prophylaxis, and biobehavioral interventions such as
HIV medication adherence interventions. Like behavio-
ral interventions, High Impact Prevention interventions
are currently being disseminated using the approach
piloted by the DEBI Project.32
Strategies are needed to better understand the proc-
esses of adaptation during EBI implementation. A
science of adaptation would provide essential informa-
tion on the ﬁt between EBIs and the context in which
they are implemented. Chambers and Norton,29 in this
issue, offer a strategy by which information on adapta-
tion and implementation variations might be captured.
The DEBI Project, including the dissemination strat-
egies, is not without limitations. Because DEBI incorpo-
rates a continuous development process, the DEBI teams
can reﬂect on these limitations and use collective insights
to make changes and implement real-time course
corrections.There are other disease prevention and health promo-
tion areas in which large-scale dissemination of evidence-
based practice is indicated. A ﬂexible, continuous devel-
opment dissemination strategy designed and imple-
mented with key stakeholders that is open to
technology exchange and practice-based innovations
may facilitate research to practice.
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